(3-氯苯基)(1,3-恶唑-2-基)甲酮 | 898759-75-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: (3-氯苯基)(1,3-恶唑-2-基)甲酮
• 英文名称: (3-chlorophenyl)(oxazol-2-yl)methanone
• 英文别名: 2-(3-Chlorobenzoyl)oxazole；(3-chlorophenyl)-(1,3-oxazol-2-yl)methanone
• CAS: 898759-75-6
• 化学式: C₁₀H₆ClNO₂
• 分子量: 207.616
• InChiKey: CKAUXCIIFHVJIO-UHFFFAOYSA-N

物化性质

• 沸点：
  349.4±44.0 °C(Predicted)
• 密度：
  1.334±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  43.1
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2934999090

反应信息

• 作为产物：
  描述：

  恶唑 、 3-氯苯甲酰氯 在 4-二甲氨基吡啶 、 三乙胺 作用下， 以 乙腈 为溶剂， 反应 24.0h， 以97%的产率得到(3-氯苯基)(1,3-恶唑-2-基)甲酮
  参考文献：
  名称：

  DMAP-Catalyzed Regel-Type Direct C-2 (Hetero)Aroylation of Oxazoles and Thiazoles Derivatives with Acid Chlorides

  摘要：

  A Regel-type transition-metal-free direct C-2 aroylation of (benzo)oxazoles, (benzo)thiazoles and 1,3,4-oxadiazoles with acid chlorides catalyzed by N,N-dimethyl-4-aminopyridine (DMAP) is described. This methodology is effective with several aroyl and heteroaroyl chlorides affording the corresponding 2-ketoazoles in moderate to excellent yields.

  DOI：

  10.1055/s-0033-1339858

文献信息

• SPIROPIPERIDINE GLYCINAMIDE DERIVATIVES
  申请人：Bissantz Caterina

  公开号：US20080171759A1

  公开（公告）日：2008-07-17

  In particular, the present invention is concerned with compounds of the general formula (I) wherein X, Y and R 1 to R 10 are as described herein. The compounds are V1a receptor antagonists. The invention also relates to the manufacture of compounds of formula I, pharmaceutical compositions containing them and their use for the treatment of anxiety and depressive disorders and other diseases.

  具体而言，本发明涉及一般式（I）中的化合物，其中X、Y和R1至R10如本文所述。这些化合物是V1a受体拮抗剂。该发明还涉及制备一般式I的化合物、含有它们的药物组合物以及它们用于治疗焦虑和抑郁症等疾病的用途。
• Regioselective Functionalization of the Oxazole Scaffold Using TMP-Bases of Mg and Zn
  作者：Diana Haas、Marc Mosrin、Paul Knochel

  DOI：10.1021/ol403019c

  日期：2013.12.20

  A general method for the synthesis of 2,4,5-trisubstituted oxazoles has been developed. Starting from commercially available oxazole, successive metalations using TMPMgCl center dot LiCl or TMPZnCl center dot LiCl led to the corresponding magnesiated or zincated species which were stable toward ring fragmentation. Furthermore, they readily reacted with various electrophiles, such as aryl and allylic halides, acid chlorides, TMSCl, and TMS-CN, providing highly functionalized oxazoles.
• US7498339B2
  申请人：——

  公开号：US7498339B2

  公开（公告）日：2009-03-03
• [EN] SPIROPIPERIDINE GLYCINAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DE SPIROPIPÉRIDINE GLYCINAMIDE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2008084005A1

  公开（公告）日：2008-07-17

  [EN] The present invention is concerned with novel spiropiperidine glycinamide derivatives as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful in the prevention and/or treatment of anxiety and depressive disorders and other diseases. In particular, the present invention is concerned with compounds of the general formula (I) wherein X, Y and R¹ to R¹⁰ are as described herein.
  [FR] La présente invention concerne des dérivés innovants de spiropipéridine glycinamide en tant qu'antagonistes du récepteur V1a, leur fabrication, les compositions pharmaceutiques qui les contiennent et leur utilisation en tant que médicaments. Les composés actifs de la présente invention sont utilisables pour la prévention et/ou le traitement de l'anxiété et des troubles dépressifs et d'autres maladies. La présente invention concerne en particulier des composés de formule générale (I) dans laquelle X, Y et R¹ à R¹⁰ sont tels que décrits ici.
• DMAP-Catalyzed Regel-Type Direct C-2 (Hetero)Aroylation of Oxazoles and Thiazoles Derivatives with Acid Chlorides
  作者：Christophe Hoarau、Pierrik Lassalas、Francis Marsais

  DOI：10.1055/s-0033-1339858

  日期：——

  A Regel-type transition-metal-free direct C-2 aroylation of (benzo)oxazoles, (benzo)thiazoles and 1,3,4-oxadiazoles with acid chlorides catalyzed by N,N-dimethyl-4-aminopyridine (DMAP) is described. This methodology is effective with several aroyl and heteroaroyl chlorides affording the corresponding 2-ketoazoles in moderate to excellent yields.